Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Pharmaceuticals (Basel, Switzerland)|July 28, 2026
In Silico Selection of GAT-1 InhibitorsKristina Stevanovic, Vladimir Perovic, Sanja Glisic, et al.Molecules (Basel, Switzerland)|May 14, 2022
In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer's DiseaseTijana Bojić, Milan Sencanski, Vladimir Perovic, et al.Molecules (Basel, Switzerland)|May 11, 2016
Arginase Flavonoid Anti-Leishmanial in Silico Inhibitors Flagged against Anti-TargetsSanja Glisic, Milan Sencanski, Vladimir Perovic, et al.Molecules (Basel, Switzerland)|August 27, 2020
Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico MethodMilan Sencanski, Vladimir Perovic, Snezana B Pajovic, et al.Frontiers in Bioscience (Landmark Edition)|September 21, 2017
Ibuprofen as a template molecule for drug design against Ebola virusSlobodan Paessler, Cheng Huang, Milan Sencanski, et al.Current Pharmaceutical Design|October 3, 2015
Natural Products as Promising Therapeutics for Treatment of Influenza DiseaseMilan Sencanski, Draginja Radosevic, Vladimir Perovic, et al.Chemistryopen|February 1, 2022
Identification of SARS-CoV-2 Papain-like Protease (PLpro) Inhibitors Using Combined Computational ApproachMilan Sencanski, Vladimir Perovic, Jelena Milicevic, et al.International Journal of Molecular Sciences|May 11, 2024
Exploring the Antiviral Potential of Natural Compounds against Influenza: A Combined Computational and Experimental ApproachVladimir Perovic, Kristina Stevanovic, Natalya Bukreyeva, et al.International Journal of Molecular Sciences|February 11, 2023
In Silico and In Vitro Inhibition of SARS-CoV-2 PLpro with Gramicidin DSara Protić, Nevena Kaličanin, Milan Sencanski, et al.International Journal of Molecular Sciences|July 12, 2025
Influenza a Virus Inhibition: Evaluating Computationally Identified Cyproheptadine Through In Vitro AssessmentSanja Glisic, Kristina Stevanovic, Andrej Perdih, et al.Pageof 11